| Entinostat in Chinese Postmenopausal Women Patients With Locally Recurrent or Metastatic Breast Cancer (NCT02833155) | Taizhou EOC Pharma Co., Ltd. | 2016-08-29 |
| Study to Assess the Bioequivalence of Ibrutinib 140 Milligram (mg) Tablet to 140 mg IMBRUVICA Capsule (NCT02877225) | Janssen Research & Development, LLC | 2016-08-29 |
| Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma (NCT02875067) | NYU Langone Health | 2016-08-29 |
| The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation (NCT03153436) | Sohag University | 2016-08-28 |
| A Study of Safety, Tolerability, and the Effects Two ND-L02-s0201 Have on the Body (NCT03241264) | Bristol-Myers Squibb | 2016-08-28 |
| A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin (NCT02995720) | Boryung Pharmaceutical Co., Ltd | 2016-08-26 |
| Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL (NCT02690545) | UNC Lineberger Comprehensive Cancer Center | 2016-08-26 |
| Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects (NCT02825836) | Telios Pharma, Inc. | 2016-08-26 |
| Intravenous Estrogen in Kidney Transplant Study (NCT03663543) | University of Pennsylvania | 2016-08-26 |
| A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant (NCT02925403) | University of Oxford | 2016-08-26 |
| A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases (NCT02780674) | Amgen | 2016-08-26 |
| Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IVIG Treatment on the Pharmacokinetics and Pharmacodynamics of LFG316 (NCT02878616) | Novartis Pharmaceuticals | 2016-08-26 |
| A Dose Finding Study of IDH305 With Standard of Care in IDH1 Mutant Acute Myeloid Leukemia (NCT02826642) | Novartis Pharmaceuticals | 2016-08-26 |
| PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer (NCT02793856) | Sichuan University | 2016-08-26 |
| Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell Lung Cancer (NCT02635061) | Celgene | 2016-08-25 |
| PfSPZ Challenge in Non-immune Adults in Baltimore, USA (NCT02780154) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-08-25 |
| Influence of Fluvoxamine on the Pharmacokinetics of BI 409306 (NCT02853136) | Boehringer Ingelheim | 2016-08-25 |
| A FIH Study to Investigate the Safety, Tolerability and PK of P218 (NCT02885506) | Medicines for Malaria Venture | 2016-08-24 |
| Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18) (NCT02658981) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-08-24 |
| Duration of Effect of Acidform Gel on Vaginal pH (NCT02693418) | Evofem Inc. | 2016-08-24 |
| Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma (NCT02895360) | Basilea Pharmaceutica | 2016-08-24 |
| Palbociclib With Everolimus + Exemestane In BC (NCT02871791) | Dana-Farber Cancer Institute | 2016-08-24 |
| Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME) (NCT02914613) | OcuTerra Therapeutics, Inc. | 2016-08-24 |
| A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects (NCT02855177) | Pfizer | 2016-08-24 |
| Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors (NCT02897778) | Syndax Pharmaceuticals | 2016-08-24 |
| A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male Subjects (NCT02829307) | GlaxoSmithKline | 2016-08-23 |
| A Study of the Safety and Tolerability of BMS-986183 in Patients With Liver Cancer (NCT02828124) | Bristol-Myers Squibb | 2016-08-23 |
| Study of Epacadostat (INCB024360) Alone and In Combination With Pembrolizumab (MK-3475) With Chemotherapy and Pembrolizumab Without Chemotherapy in Participants With Advanced Solid Tumors (MK-3475-434) (NCT02862457) | Merck Sharp & Dohme LLC | 2016-08-23 |
| A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib) (NCT02900664) | Novartis Pharmaceuticals | 2016-08-23 |
| A Study of SHR-1314 in Healthy Subjects (NCT02934412) | Atridia Pty Ltd. | 2016-08-22 |
| Transporter Cocktail Mutual Interaction (NCT02854527) | Boehringer Ingelheim | 2016-08-22 |
| Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas (NCT02829931) | H. Lee Moffitt Cancer Center and Research Institute | 2016-08-22 |
| Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program (NCT02673255) | Biomat USA, Inc. | 2016-08-22 |
| Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes. (NCT02877355) | Novo Nordisk A/S | 2016-08-22 |
| A Trial of mFOLFIRI With MEK162 in Patients With Advanced RAS (HRAS, NRAS, or KRAS) Positive Metastatic Colorectal Cancers (NCT02613650) | University of Utah | 2016-08-19 |
| A Study of a Single Subcutaneous Dose of ALXN1210 in Healthy Adult Participants (NCT05288829) | Alexion Pharmaceuticals, Inc. | 2016-08-19 |
| Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity (NCT02870231) | Novo Nordisk A/S | 2016-08-18 |
| Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer (NCT02826434) | Massachusetts General Hospital | 2016-08-18 |
| Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia (NCT02631252) | Alison Sehgal, MD, MS | 2016-08-18 |
| Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer (NCT02718066) | HUYABIO International, LLC. | 2016-08-18 |
| Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects (NCT02705989) | Bristol-Myers Squibb | 2016-08-18 |
| Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064 (NCT03918980) | Novartis Pharmaceuticals | 2016-08-18 |
| Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants (NCT01512888) | St. Jude Children's Research Hospital | 2016-08-17 |
| Dermal Phototoxicity Study (NCT04070742) | Vyne Therapeutics Inc. | 2016-08-17 |
| Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195 (NCT02881853) | Xencor, Inc. | 2016-08-17 |
| Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteers (NCT03208218) | Samyang Biopharmaceuticals Corporation | 2016-08-17 |
| Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer (NCT02903069) | Celgene | 2016-08-17 |
| A Study to Evaluate the Pharmacokinetic Exposure of 2 Formulations of Apremilast in Healthy Adults (NCT02777554) | Amgen | 2016-08-17 |
| H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults (NCT02624219) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-08-16 |
| A Study To Evaluate The Effect Of Itraconazole On Pharmacokinetics Of PF-06463922 In Healthy Volunteers (NCT02838264) | Pfizer | 2016-08-16 |
| OCR002-SP103 - Oral Immediate Release Study (NCT03846843) | Ocera Therapeutics, Inc. | 2016-08-15 |
| HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection (NCT02343666) | Fred Hutchinson Cancer Center | 2016-08-15 |
| A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS (NCT02732184) | Immedica Pharma AB | 2016-08-15 |
| AGA Biocellular Stem/Stromal Hair Regenerative Study (NCT02849470) | Healeon Medical Inc | 2016-08-14 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274 (NCT02852395) | Janssen-Cilag International NV | 2016-08-13 |
| A Study of the Relative Bioavailability of BMS-626529 Administered as BMS-663068 From 150mg Low-dose Extended-release Tablets Compared to 600mg Reference Extended-release Tablets in Healthy Subjects (NCT02859259) | ViiV Healthcare | 2016-08-12 |
| A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors (NCT02834247) | Calithera Biosciences, Inc | 2016-08-12 |
| Study to Evaluate the Safety and Tolerability of AMG 986 in Healthy Volunteers and Heart Failure Patients (NCT03276728) | Amgen | 2016-08-12 |
| Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) (NCT02834390) | Daiichi Sankyo Co., Ltd. | 2016-08-12 |
| PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer (NCT02837263) | University of Wisconsin, Madison | 2016-08-11 |
| Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients (NCT02809573) | Chipscreen Biosciences, Ltd. | 2016-08-11 |
| Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AML (NCT02891278) | Columbia University | 2016-08-11 |
| Safety and Immunogenicity of HIV DNA-C CN54ENV and Recombinant HIV CN54gp140 Vaccines in Healthy Volunteers (NCT02589795) | Imperial College London | 2016-08-11 |
| A Study of a Vaccine for Pneumonia in Adults and Toddlers in Kenya (NCT02543892) | PATH | 2016-08-10 |
| Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa (NCT02793960) | Shasa Hu | 2016-08-10 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2027 in Healthy Subjects (NCT02873156) | Eisai Inc. | 2016-08-10 |
| A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer (NCT02860780) | Eli Lilly and Company | 2016-08-10 |
| Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male Volunteers (NCT02852824) | Boehringer Ingelheim | 2016-08-10 |
| Phase 1/2 Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial of Losartan to Treat Grade II & III Hamstring Strains (NCT02263729) | James J. Irrgang | 2016-08-10 |
| INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer (NCT02764086) | Cancer Trials Ireland | 2016-08-10 |
| Ibuprofen and Pseudoephedrine Comparative Pharmacokinetic Study (NCT03184766) | Reckitt Benckiser Healthcare (UK) Limited | 2016-08-10 |
| Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors (NCT03050450) | Johns Hopkins All Children's Hospital | 2016-08-10 |
| Study to Evaluate the Safety and Pharmacokinetics of MEDI9090 in Subjects With Advanced Solid Tumors (NCT02900157) | MedImmune LLC | 2016-08-09 |
| Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly Japanese, and Healthy Younger Adult Japanese Subjects (NCT02857777) | Janssen Research & Development, LLC | 2016-08-09 |
| Safety, Tolerability, Pharmacokinetic and Absolute Bioavailability Study of JNJ-63623872 Administered as an Intravenous Infusion and a 600-Milligram (mg) Oral Dose in Healthy Adults (NCT02860806) | Janssen-Cilag International NV | 2016-08-08 |
| Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris (NCT03132194) | Sun Pharmaceutical Industries, Inc. | 2016-08-08 |
| Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer (NCT02868632) | NYU Langone Health | 2016-08-07 |
| Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery (NCT02713373) | Roswell Park Cancer Institute | 2016-08-05 |
| Pilot Study of Bisphosphonates for Breast Cancer (NCT02781805) | University of Wisconsin, Madison | 2016-08-05 |
| To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects. (NCT02853435) | GlaxoSmithKline | 2016-08-04 |
| A Study to Assess the Pharmacokinetics, Efficacy, and Safety of Atezolizumab Administered Intravenously (IV) as a Single Agent or in Combination With Chemotherapy in Chinese Participants With Locally Advanced or Metastatic Solid Tumors (NCT02825940) | Hoffmann-La Roche | 2016-08-04 |
| Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Pembrolizumab (MK-3475) in Chinese Participants With Non-Small-Cell Lung Cancer (MK-3475-032/KEYNOTE-032) (NCT02835690) | Merck Sharp & Dohme LLC | 2016-08-04 |
| Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism (NCT02864810) | Asan Foundation | 2016-08-04 |
| Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer (NCT02621398) | Rutgers, The State University of New Jersey | 2016-08-04 |
| Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers (NCT02584244) | Lumicell, Inc. | 2016-08-04 |
| Multiple Donor Treg DLI for Severe Refractory Chronic GVHD (NCT02749084) | Mario Arpinati | 2016-08-03 |
| Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors (NCT02810418) | National Cancer Institute (NCI) | 2016-08-03 |
| European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors (NCT02813135) | Gustave Roussy, Cancer Campus, Grand Paris | 2016-08-03 |
| Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation (NCT02702427) | St. Anna Kinderkrebsforschung | 2016-08-03 |
| sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer (NCT02767921) | University of Southern California | 2016-08-02 |
| Single Dose and Multiple Dose Escalation Trial of an Oral Formulation of MRX-4 (NCT03033342) | MicuRx | 2016-08-02 |
| Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults (NCT02840487) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-08-02 |
| Study of Different Forms of Danicopan (Tablet, Softgel Capsule, Liquid-filled Capsule) in Healthy Participants (NCT04940559) | Alexion Pharmaceuticals, Inc. | 2016-08-02 |
| Development of a Polyphenol-rich Dietary Preparation for Treating Veterans With Gulf War Illness (NCT02915237) | Icahn School of Medicine at Mount Sinai | 2016-08-01 |
| Pharmacokinetics and Metabolism Study of Radiolabeled BMS-986142 in Healthy Male Subjects (NCT02880670) | Bristol-Myers Squibb | 2016-08-01 |
| Effect of Background Noise on Sleep Quality (NCT02945254) | Brigham and Women's Hospital | 2016-08-01 |
| Chimeric Switch Receptor Modified T Cells for Patients With PD-L1+ Recurrent or Metastatic Malignant Tumors (NCT02930967) | China Meitan General Hospital | 2016-08-01 |
| SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer (NCT02581787) | Maximilian Diehn | 2016-08-01 |
| PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor (Lung, Liver and Stomach) (NCT02862028) | Shanghai International Medical Center | 2016-08-01 |
| Single Dose, Repeated Dose, and Conditional Food Effect Study of PF-05221304 in Healthy Subjects (NCT02871037) | Pfizer | 2016-08-01 |